GILEAD SCIENCES, INC. (GILD) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing

ACC: 0001310204-26-000018open_in_new

Total Value$162.9K

Trades3

Insiders1

Transaction Details

Dickinson Andrew D

Chief Financial Officer·Direct

Exercise · Dispose

Restricted Stock UnitDerivative

Shares-2.80K

Price-

Total Value$0

Shares Owned After27.85K

Transaction DateJun 10, 2026

Footnotes ▸

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Dickinson Andrew D

Chief Financial Officer·Direct

Tax W/H · Dispose

Common Stock

Shares-1.34K

Price$121.48

Total Value$162.9K

Shares Owned After174.65K

Transaction DateJun 10, 2026

Dickinson Andrew D

Chief Financial Officer·Direct

Exercise · Acquire

Common Stock

Shares+2.80K

Price-

Total Value$0

Shares Owned After175.99K

Transaction DateJun 10, 2026

Footnotes ▸

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Post-Transaction Holdings

Dickinson Andrew D

Security	Shares	Change
Common Stock	174.65K	+1.46K (0.84%)
Restricted Stock Unit	27.85K	-2.80K (-9.12%)

Original SEC Filing Textexpand_more

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-10 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: Dickinson Andrew D CIK: 0001310204 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-10 | Code: M (Exercise of derivative) Shares: +2,796 Shares Owned After: 175,987 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [Transaction #2] Security: Common Stock Date: 2026-06-10 | Code: F (Payment of exercise/tax) Shares: -1,341 | Price: $121.48 Total Value: $162,904.68 Shares Owned After: 174,646 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-06-10 | Code: M (Exercise of derivative) Shares: -2,796 Shares Owned After: 27,851 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Footnotes (Complete Index) --- F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Signature --- /s/ /s/ Amy Kim by Power of Attorney for Andrew D. Dickinson (2026-06-11)